Every day, your heart works tirelessly, pumping blood that delivers the oxygen and nutrients your body needs to function. February is American Heart Month, a reminder that understanding your heart, ...

Please provide your email address to receive an email when new articles are posted on . An AI model accurately distinguished cardiac amyloidosis from other phenotypic mimics. The model also showed ...

Amyloidosis represents a heterogeneous group of disorders defined by the extracellular deposition of misfolded protein fibrils, which can cause severe impairment in multiple organs. In the context of ...

This transcript has been edited for clarity. Gayatri Acharya, MD: Greetings. I'm Dr Gayatri Acharya, cardiology fellow at Mayo Clinic. During today's roundtable, we'll be discussing cardiac ...

I 124 evuzamitide is an investigational PET radiotracer–a radioactive diagnostic imaging agent injected into the body before ...

Armed with new phase 3 data, Bayer is preparing to file for approval of a new PET imaging agent that could accelerate the ...

Most older adults with transthyretin cardiac amyloidosis face a several-month delay in diagnosis after a heart failure ...

A promising new way to diagnose transthyretin amyloid cardiomyopathy (ATTR-CM or -CA) has the field waiting in anticipation. Early-phase research suggests that the positron emission tomography ...

An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in Oxford, England, is highly accurate in screening for cardiac amyloidosis, a ...

Investigators in Italy report that CA may be underdiagnosed in women due to sex differences in left ventricular wall thickness. Current diagnostic criteria may not accurately reflect disease severity ...

Cardiac amyloidosis, particularly transthyretin amyloid cardiomyopathy (ATTR-CM), is a rare but serious condition where misfolded proteins stiffen the heart muscle. It’s often underdiagnosed due to ...

Please provide your email address to receive an email when new articles are posted on . Cardiac MRI data suggest acoramidis could improve outcomes for people with symptomatic transthyretin amyloid ...